1 study found for:
10204484 [PUBMED-IDS]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 |
Terminated
Has Results |
Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer
|
† Indicates status has not been verified in more than two years